⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Shanyu Pill
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-04 — Effects of Shanyu Pill in Older Adults With Sarcopenia: Protocol registered for a 24-week multicenter double-blind placebo-controlled RCT (n=192) of Shanyu Pill in older adults with sarcopenia; primary outcome is change in appendicular skeletal muscle mass index, with secondary strength, physical performance, cognition, and TCM Spleen Qi Deficiency score endpoints plus gut–muscle–brain mechanistic substudies — trial launch only, no efficacy readout. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Effects of Shanyu Pill in Older Adults With Sarcopenia
04-sep-2026
novelty 3
per-area 3
strengthens